background preloader

Methamphetamine

Methamphetamine[note 1] (pronunciation: /ˌmɛθæmˈfɛtəmiːn/; contracted from N-methyl-alpha-methylphenethylamine) is a neurotoxin and potent psychostimulant of the phenethylamine and amphetamine classes that is used to treat attention deficit hyperactivity disorder (ADHD) and obesity. Methamphetamine exists as two enantiomers, dextrorotary and levorotary.[note 2] Dextromethamphetamine is a stronger central nervous system (CNS) stimulant than levomethamphetamine; however, both are addictive and produce the same toxicity symptoms at high doses. Methamphetamine may be sold illegally, either as pure dextromethamphetamine or in an equal parts mixture of the right and left handed molecules (i.e., 50% levomethamphetamine and 50% dextromethamphetamine). In low doses, methamphetamine can cause an elevated mood and increase alertness, concentration, and energy in fatigued individuals. Uses Medical Recreational Desoxyn tablets – pharmaceutical methamphetamine hydrochloride Contraindications Side effects

Methylphenidate Methylphenidate (trade names Concerta, Methylin, Ritalin, Equasym XL) is a psychostimulant drug and substituted phenethylamine approved for treatment of attention-deficit hyperactivity disorder (ADHD), postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity. Uses[edit] Medical[edit] MPH is a commonly prescribed psychostimulant and works by increasing the activity of the central nervous system.[5] It produces such effects as increasing or maintaining alertness, combating fatigue, and improving attention.[6] The short-term benefits and cost effectiveness of methylphenidate are well established, although long-term effects are unknown.[7][8] The long term effects of methylphenidate on the developing brain are unknown. Attention deficit hyperactivity disorder[edit] Mechanisms of ADHD[edit] Other[edit]

Methylhexanamine Chemical compound Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.[2] Since 2006 methylhexanamine has been sold extensively under many names as a stimulant or energy-boosting dietary supplement under the claim that it is similar to certain compounds found in geraniums, but its safety has been questioned as a number of adverse events and at least five deaths have been associated with methylhexanamine-containing supplements.[3] It is banned by many sports authorities and governmental agencies. History[edit] Marketing as dietary supplement[edit] Patrick Arnold reintroduced methylhexanamine in 2006 as a dietary supplement,[7][8] after the final ban of ephedrine in the United States in 2005.

Methcathinone Psychoactive stimulant Methcathinone (α-methylamino-propiophenone or ephedrone) (sometimes called "cat" or "jeff" or "catnip" or "M-Kat" or "kat" or "intash" ) is a monoamine alkaloid and psychoactive stimulant, a substituted cathinone. It is used as a recreational drug due to its potent stimulant and euphoric effects and is considered to be addictive, with both physical and psychological withdrawal occurring if its use is discontinued after prolonged or high-dosage administration.[1] It is usually snorted, but can be smoked, injected, or taken orally. Methcathinone is listed as a Schedule I controlled substance by the Convention on Psychotropic Substances and the United States' Controlled Substances Act, and as such it is not considered to be safe or effective in the treatment, diagnosis, prevention, or cure of any disease, and has no approved medical use. History[edit] Chemistry[edit] Methcathinone possesses a chiral carbon atom, and therefore two enantiomers are possible. Effects[edit]

Understand - a novelette by Ted Chiang I 'm in the middle of retouching a holograph when the phone rings. I waver between the phone and the console, and reluctantly opt for the phone. I'd normally have the answering machine take any calls when I'm editing, but I need to let people know I'm working again. I lost a lot of business when I was in the hospital: one of the risks of being a freelancer. "Hey Leon, it's Jerry." "Hi Jerry. "You interested in seeing a movie tonight? "Tonight? "What's that?" "It's called . "Is this some kind of Shakespearean soliloquy?" Too much: with that lighting, the outer edges will be too bright. "I didn't know you were such a fan of poetry." After checking all the numbers once more, I let the computer recalculate the interference pattern. "Thanks, but I think we'll stick with the movie." "Okay, you guys have fun. Suddenly it occurs to me what's just happened. Will the surprises never end? And now I find I can concentrate on two things at once; something I never would have predicted. "Good," says Dr.

Mephedrone Synthetic stimulant drug Mephedrone, also known as 4-methylmethcathinone, 4-MMC, and 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include drone,[3] M-CAT,[4] White Magic,[5] and meow meow.[6] It is chemically similar to the cathinone compounds found in the khat plant of eastern Africa.[3][7] It comes in the form of tablets or crystals,[8] which users can swallow, snort or inject, producing effects similar to those of MDMA, amphetamines and cocaine. In addition to its stimulant effects, mephedrone produces side effects, of which bruxism is the most common. Mephedrone was first synthesised in 1929, but did not become widely known until it was rediscovered in 1999–2000 at which point it was legal to produce and possess in many countries. Uses[edit] Recreational[edit] Available forms[edit] Purity[edit] Adverse effects[edit] Short-term effects[edit] Neurotoxicity[edit] Reinforcement disorders[edit] Overdose[edit] Toxicity[edit] Deaths[edit]

Methoxetamine Dissociative drug Methoxetamine, abbreviated as MXE, is a dissociative hallucinogen that has been sold as a designer drug.[3][4] It differs from many dissociatives such as ketamine and phencyclidine (PCP) that were developed as pharmaceutical drugs for use as general anesthetics in that it was designed specifically for recreational use.[4][5] Due to its structural similarity to ketamine, it is no longer produced in sizeable quantities due to near-global bans. It is a rare example of a drug being so widely controlled without having an existing medical use. MXE is an arylcyclohexylamine.[6] It acts mainly as an NMDA receptor antagonist, similarly to other arylcyclohexylamines like ketamine and PCP.[6] Recreational use[edit] Effects[edit] Pharmacology[edit] Pharmacodynamics[edit] Pharmacokinetics[edit] MXE has a longer duration of action than that of ketamine.[17] Chemistry[edit] Methoxetamine and related arylcyclohexylamines. MXE hydrochloride is soluble in ethanol up to 10 mg/ml at 25 °C.[18] Utah

Marginal utility Marginality[edit] The term marginal refers to a small change, starting from some baseline level. As Philip Wicksteed explained the term, "Marginal considerations are considerations which concern a slight increase or diminution of the stock of anything which we possess or are considering"[2] In practice the smallest relevant division may be quite large. Utility[edit] Depending on which theory of utility is used, the interpretation of marginal utility can be meaningful or not. Contemporary mainstream economic theory frequently defers metaphysical questions, and merely notes or assumes that preference structures conforming to certain rules can be usefully proxied by associating goods, services, or their uses with quantities, and defines "utility" as such a quantification.[5] Though generally pursued outside of the mainstream methods, there are conceptions of utility that do not rely on quantification. Diminishing marginal utility[edit] Marginalist theory[edit] Adam Smith to state is Moreover, if and

p-Hydroxynorephedrine p-Hydroxynorephedrine (PHN), or 4-hydroxynorephedrine, is the para-hydroxy analog of norephedrine and an active sympathomimetic metabolite of amphetamine in humans.[1][2] When it occurs as a metabolite of amphetamine, it is produced from both p-hydroxyamphetamine and norephedrine.[2][3][4] [edit] Notes[edit] ^ 4-Hydroxyamphetamine has been shown to be metabolized into 4-hydroxynorephedrine by dopamine beta-hydroxylase (DBH) in vitro and it is presumed to be metabolized similarly in vivo.[6][11] Evidence from studies that measured the effect of serum DBH concentrations on 4-hydroxyamphetamine metabolism in humans suggests that a different enzyme may mediate the conversion of 4-hydroxyamphetamine to 4-hydroxynorephedrine;[11][13] however, other evidence from animal studies suggests that this reaction is catalyzed by DBH in synaptic vesicles within noradrenergic neurons in the brain.[14][15] See also[edit] Hydroxynorephedrine References[edit] References[edit] External links[edit]

Methadone Opioid medication used for pain; also to treat dependency on opioids Methadone, sold under the brand names Dolophine and Methadose among others, is a synthetic opioid agonist used for chronic pain and also for opioid dependence.[5] It is used to treat chronic pain, and it is also used to treat addiction to heroin or other opioids.[8][9] Prescribed for daily use, the medicine relieves cravings and removes withdrawal symptoms.[10] Detoxification using methadone can be accomplished in less than a month, or it may be done gradually over as long as six months.[5] While a single dose has a rapid effect, maximum effect can take up to five days of use.[5] The pain-relieving effects last about six hours after a single dose.[5][11] After long-term use, in people with normal liver function, effects last 8 to 36 hours.[5][7] Methadone is usually taken by mouth and rarely by injection into a muscle or vein.[5] Medical uses[edit] Opioid addiction[edit] Pain[edit] Adverse effects[edit] Physical symptoms

Executive functions Executive functions (also known as cognitive control and supervisory attentional system) is an umbrella term for the management (regulation, control) of cognitive processes, including working memory, reasoning, flexibility, and problem solving as well as planning and execution.[1][2][3] The prefrontal areas of the frontal lobe are necessary but not solely sufficient for executive functions. Neuroanatomy[edit] Historically, the executive functions have been seen as regulated by the prefrontal regions of the frontal lobes, but it is still a matter of ongoing debate if that really is the case. Even though articles on prefrontal lobe lesions commonly refer to disturbances of executive functions and vice versa, a review found indications for the sensitivity but not for the specificity of executive function measures to frontal lobe functioning. This means that both frontal and non-frontal brain regions are necessary for intact executive functions. Hypothesized role[edit] Development[edit]

4-Hydroxyamphetamine Group of stereoisomers 4-Hydroxyamphetamine (4HA), also known as hydroxyamfetamine, hydroxyamphetamine, oxamphetamine, norpholedrine, para-hydroxyamphetamine, and α-methyltyramine, is a drug that stimulates the sympathetic nervous system. It is used medically in eye drops to dilate the pupil (a process called mydriasis), so that the back of the eye can be examined. It is also a major metabolite of amphetamine and certain substituted amphetamines. Medical use[edit] 4-Hydroxyamphetamine is used in eye drops to dilate the pupil (a process called mydriasis) so that the back of the eye can be examined. 4-hydroxyamphetamine has some limitations to its use as a diagnostic tool. Pharmacology[edit] Like amphetamine, 4-hydroxyamphetamine is an agonist of human TAAR1.[4] 4-Hydroxyamphetamine acts as an indirect sympathomimetic and causes the release of norepinephrine from nerve synapses which leads to mydriasis (pupil dilation).[3][5] Commercialization[edit] See also[edit] Notes[edit] References[edit]

5-Methoxymethylone Chemical compound of the cathinone class Legal Status[edit] 5-Methoxymethylone is listed as an illegal drug under the name 2-A1MP in Hungary.[5] See also[edit] References[edit] Parkinson's Law UK First edition book cover Originally, Parkinson's law is the adage that "work expands so as to fill the time available for its completion", and the title of a book which made it well-known. However, in current understanding, Parkinson's law is a reference to the self-satisfying uncontrolled growth of the bureaucratic apparatus in an organization. History[edit] Articulated by Cyril Northcote Parkinson as part of the first sentence of a humorous essay published in The Economist in 1955 and since republished online,[1][2] it was reprinted with other essays in the book Parkinson's Law: The Pursuit of Progress (London, John Murray, 1958). A current form of the law is not the one Parkinson refers to by that name in the article, but a mathematical equation describing the rate at which bureaucracies expand over time. Parkinson's Law was translated into many languages. Corollaries[edit] If you wait until the last minute, it only takes a minute to do.[5] the Asimov corollary to Parkinson's law:

Related: